首页> 美国卫生研究院文献>other >Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone

【2h】

Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone

机译：醋酸阿比特龙+泼尼松治疗无化疗生存期转移性去势抵抗前列腺癌的无进展生存期预后指标模型

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundRadiographic progression-free survival (rPFS) is associated with overall survival (OS) in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients. Using readily assessable baseline clinical and laboratory parameters, we developed a prognostic index model for rPFS in chemotherapy-naïve mCRPC patients without visceral disease who were treated with abiraterone acetate plus prednisone.

机译：背景：无初治的转移性去势抵抗性前列腺癌（mCRPC）患者的放射无进展生存期（rPFS）与总生存期（OS）相关。使用易于评估的基线临床和实验室参数，我们开发了未经乙酸治疗的无内脏疾病的初治mCRPC患者（使用醋酸阿比特龙酯+泼尼松治疗）的rPFS的预后指标模型。

著录项

期刊名称 other
作者
Charles J. Ryan; Thian Kheoh; Jinhui Li; Arturo Molina; Peter De Porre; Joan Carles; Eleni Efstathiou; Philip W. Kantoff; Peter F.A. Mulders; Fred Saad; Kim N. Chi;
展开▼
作者单位

展开▼
年(卷),期 -1(S1558-7673),1730211-2
年度 -1
页码 S1558-7673(17)30211-2
总页数 14
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT [J] . Farnebo Jacob, Wadelius Agnes, Sandstrom Per, Medicine. . 2016,第31期

机译：可以使用连续的C11-醋酸酯PET / CT预测使用醋酸阿比特龙治疗的转移性去势抵抗性前列腺癌的无进展生存期和总生存期
2. Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT [J] . Farnebo Jacob, Wadelius Agnes, Sandstrom Per, Medicine. . 2016,第31期

机译：可以预测通过连续C11-醋酸乙酸酯（乙酸酯）预测乙酸酯治疗的转移性阉割抗性前列腺癌中的无进展和整体存活
3. Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate [J] . Attard Gerhardt, de Bono Johann S., Logothetis Christopher J., Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第7期

机译：醋酸阿比特龙治疗ERG基因状态分层转移抵抗去势抵抗的前列腺癌患者无影像学进展的改善。
4. Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer: A Decade of Progress and Ongoing Discoveries [C] . Leonel Hernez-Aya, Maha Hussain Genitourinary Cancers Symposium. . 2014

机译：转移激素敏感和阉割的前列腺癌：进步和持续发现的十年
5. Transcription-Based Molecular Imaging and Gene Therapy for Castration-resistant and Metastatic Prostate Cancer in Translational Models [D] . Jiang, Ziyue 2013

机译：基于转录的分子模型和基因治疗转化模型中去势抵抗和转移性前列腺癌的研究
6. A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel [O] . K. N. Chi, T. Kheoh, C. J. Ryan, -1

机译：预测多西他赛治疗后接受醋酸阿比特龙治疗的转移性去势抵抗性前列腺癌患者总生存的预后指标模型
7. Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone [O] . Charles J. Ryan, Thian Kheoh, Jinhui Li, 2018

机译：预后指数模型用于化疗 - 幼稚转移性阉割抗阉割前列腺癌的无进展生存率醋酸盐加上泼尼松

Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone

摘要

著录项

相似文献

相关主题

期刊订阅